Vaccination

The University of Oxford announced recently that researchers initiated the first-in-human trial of a Marburg virus vaccine to test its safety and evaluate its immune response among a young, healthy population.

Almost one-third of people do not plan on receiving recommended vaccinations this fall, according to the results of a recent survey from the Ohio State University Wexner Medical Center.

An experimental vaccine failed to prevent Clostridioides difficile infection in a phase 3 trial but successfully reduced the duration of symptoms, infections requiring medical attention and antibiotic treatments, researchers reported.

Protecting immunocompromised individuals from infections like herpes zoster is an ongoing challenge for every rheumatologist.

Children with tracheostomy and home ventilation had low COVID-19 vaccination rates, especially for boosters, despite higher than average influenza vaccination coverage, according to a study published in JAMA Network Open.

Although vaccines have reduced the burden of pneumococcal disease, pneumonia due to Streptococcus pneumoniae and invasive pneumococcal disease remains prevalent.

Girls with diagnosed mental health conditions had lower HPV vaccination coverage than their peers without mental health conditions, according to a study published in The Lancet Public Health.

Clinicians could help patients overcome vaccine hesitancy by highlighting the potential harms of not being vaccinated rather than emphasizing the benefits of a vaccine, according to a study published in the Journal of Public Health.

WHO this week announced that cholera cases increased by 13% and cholera deaths increased by 71% globally in 2023.